PERCEPTIVE ADVISORS LLC 13D and 13G filings for Contineum Therapeutics, Inc. Class A Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:26 pm Sale | 2025-06-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | PERCEPTIVE ADVISORS LLC | 699,486 3.200% | -741,763 (-51.47%) | Filing |
| 2025-05-15 4:30 pm Unchanged | 2025-03-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | PERCEPTIVE ADVISORS LLC | 1,441,249 7.500% | 0 (Unchanged) | Filing |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | PERCEPTIVE ADVISORS LLC | 1,441,249 5.600% | 1,441,249 (New Position) | Filing |